Physician profile
Dongjin Suh
NPI 1588231427
$5,566.92
in general payments reported to CMS, 2019-2025
7 companies · $1,304 in 2025
The $1,304 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $582 · 2022: $163 · 2024: $3,517 · 2025: $1,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,180 · Food and Beverage: $1,502 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,180.00 |
| Food and Beverage | $1,502.07 |
| Education | $139.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,470.54 | 2022-2024 | Endurant Iis, Hawkone |
| W. L. Gore & Associates, INC. | $1,200.88 | 2021-2025 | Gore Excluder Aaa Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Bolton Medical INC | $389.71 | 2024-2025 | Treo Abdominal Stent-Graft System, Gelweave, Relay Thoracic Stent-Graft With Plus Delivery System |
| Philips North America LLC | $164.44 | 2025 | Peripheral Vascular Undivided, Labosys |
| Shockwave Medical, INC | $160.69 | 2025 | |
| Becton, Dickinson and Company | $137.02 | 2025 | Rotarexs 6 F X 135 Cm |
| Penumbra, INC. | $43.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dongjin Suh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.